Refine
Year of publication
Document Type
- Article (77)
- Preprint (36)
- Conference Proceeding (4)
- Report (2)
- Working Paper (2)
Has Fulltext
- yes (121)
Is part of the Bibliography
- no (121)
Keywords
- liver transplantation (5)
- Liver transplantation (4)
- Liver diseases (3)
- COVID-19 (2)
- Cirrhosis (2)
- Hadron-Hadron Scattering (2)
- Hepatitis C virus (2)
- Hepatocellular carcinoma (2)
- SARS-CoV-2 (2)
- acute myeloid leukemia (2)
- amyloid precursor protein (2)
- childhood acute myeloid leukemia (2)
- cirrhosis (2)
- hippocampus (2)
- influenza (2)
- out-patient paediatrics (2)
- presynaptic active zone (2)
- relapse (2)
- respiratory tract infection (2)
- salvage therapy (2)
- 232Th (1)
- 234-238U calculated B (E2) values (1)
- 3years (1)
- ACLF (1)
- Acute myeloid leukemia (1)
- All-trans retinoic acid (1)
- Ansiedlung (1)
- Antiangiogenesis (1)
- Antiretroviral therapy (1)
- Antiretrovirals (1)
- Artificial Intelligence (1)
- Autologous stem cell transplantation (1)
- BCR signaling (1)
- BTK (1)
- Biodiversity Data (1)
- Biomarker (1)
- Biomonitoring (1)
- Bipolar disorder (1)
- Blood (1)
- Botanical Collections (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- Cancer treatment (1)
- Computed axial tomography (1)
- Conservation (1)
- DLBCL (1)
- DME (1)
- DNA methylation (1)
- DNA-Specific Labelling (1)
- DTHR (1)
- Death rates (1)
- Depression (1)
- Diabetes mellitus (1)
- Digitization (1)
- Dimer Yield Ratio (1)
- Elimination of Rho Factor (1)
- Endocrine cancer (1)
- Extended donor criteria (1)
- Far UV (1)
- Folic Acid Antagonists (1)
- Genetics (1)
- Germany (1)
- Graft function (1)
- Graft survival (1)
- HIV (1)
- HIV-1 (1)
- Herbaria (1)
- High-dose chemotherapy (1)
- Hispanic people (1)
- ILUVIEN (1)
- IgG4-related disease (1)
- Immune suppression (1)
- Immunology (1)
- Indeterminate biliary stricture (1)
- Kinetics of Dimer Formation (1)
- LTP (1)
- Lebensweise (1)
- Lenalidomide (1)
- Marginal grafts (1)
- Medication Appropriateness Index (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Multiple myeloma (1)
- NETs (1)
- NSF (1)
- Nephrons (1)
- Neuroendocrine cancer (1)
- Neuroscience (1)
- Neutrophils (1)
- Next-generation sequencing (1)
- Nucleophosmin-1 (1)
- Oncology (1)
- Organ rinse (1)
- Organ shortage (1)
- PCR (1)
- Pelzbiene (1)
- ROS/RNS (1)
- Radiation exposure (1)
- Radical nephrectomy (1)
- Relapse (1)
- Renal cancer (1)
- Renal system (1)
- Research Infrastructure (1)
- Retro-IDEAL (1)
- Second-line treatment (1)
- Semantics (1)
- Sorafenib (1)
- Steroid (1)
- Surgical and invasive medical procedures (1)
- Surgical oncology (1)
- Survival analysis (1)
- Tacrolimus (1)
- Taxonomy (1)
- Tetrad Analysis (1)
- Thin Layer Chromatography (1)
- Thymidylate Low Requirement (1)
- Thymidylate Sensitivity (1)
- Thymidylate Synthetase (1)
- Thymidylate Uptake (1)
- Thymine Dimers (1)
- Transarterial chemoembolization (1)
- Umsiedlung (1)
- Verbreitung (1)
- acoustic radiation force impulse (1)
- acute chronic inflammation (1)
- acute-on-chronic liver failure (1)
- aftercare structures (1)
- aging (1)
- analgesia (1)
- antimicrobial stewardship (1)
- antisynthetase antibodies (1)
- antisynthetase syndrome (1)
- arthritis (1)
- artificial intelligence (1)
- bile duct stenosis (1)
- biliary stricture (1)
- carbapenem resistance (1)
- cardiac arrest (1)
- case study (1)
- cell therapy (1)
- cholangiocarcinoma (1)
- chronic hepatitis C (1)
- collective model (1)
- combination therapy (1)
- computer-assisted drug therapy (1)
- data science (1)
- death rates (1)
- direct antiviral agents (1)
- direct-acting antiviral (DAA) treatment (1)
- endoscopic retrograde cholangiopancreatography (1)
- endoscopy (1)
- enterobacter infections; pseudomonas aeruginosa; epidemiology (1)
- eosinophilic cholangitis (1)
- epidemiology (1)
- ethical trade-off (1)
- explainable AI (1)
- gadobutrol (1)
- graft rejection (1)
- graft-versus host (1)
- head-and-neck cancer (1)
- healthcare (1)
- hepatitis C (1)
- hospital exemption (1)
- human pain models (1)
- human pharmacology (1)
- immunohistochemistry (1)
- infection control (1)
- interferon-free antiviral treatment (1)
- interstitial lung disease (1)
- ischemic type biliary lesions (1)
- liver cirrhosis (1)
- liver transplantation center (1)
- long-term outcome (1)
- lung cancer (1)
- mechanical ventilation (1)
- medical risk factors (1)
- medication reconciliation (1)
- mesenchymal stromal cell (1)
- metastasis (1)
- microdosing (1)
- microsatellite instability (1)
- mitochondria (1)
- multidrug resistance (1)
- multimorbidity (1)
- multiple chronic conditions (1)
- myositis (1)
- neuronal network (1)
- orthopic liver transplantation (1)
- pain (1)
- pediatric (1)
- pediatric patients (1)
- polypharmacy (1)
- portal hypertension (1)
- post-liver transplantation management (1)
- primary sclerosing cholangitis (1)
- proteomics (1)
- pseudomonas aeruginosa (1)
- pulmonary failure (1)
- recurrent cholangitis (1)
- refractory aGvHD (1)
- renal impairment (1)
- respiratory failure (1)
- short-course antibiotic therapy (1)
- sphingolipids (1)
- steroid-resistant aGvHD (1)
- synapse (1)
- transient elastography (1)
- transmission (1)
- transplantation (1)
- trust (1)
- trustworthy AI (1)
- whole-genome sequencing (1)
Institute
- Physik (63)
- Informatik (47)
- Frankfurt Institute for Advanced Studies (FIAS) (45)
- Medizin (44)
- Biowissenschaften (8)
- Geowissenschaften (3)
- Exzellenzcluster Makromolekulare Komplexe (2)
- Biochemie, Chemie und Pharmazie (1)
- ELEMENTS (1)
- Erziehungswissenschaften (1)
Objectives: The aim of this multicenter retrospective study was to investigate safety and efficacy of direct acting antiviral (DAA) treatment in the rare subgroup of patients with HCV/HIV-coinfection and advanced liver cirrhosis on the liver transplant waiting list or after liver transplantation, respectively.
Methods: When contacting 54 German liver centers (including all 23 German liver transplant centers), 12 HCV/HIV-coinfected patients on antiretroviral combination therapy were reported having received additional DAA therapy while being on the waiting list for liver transplantation (patient characteristics: Child-Pugh A (n = 6), B (n = 5), C (n = 1); MELD range 7–21; HCC (n = 2); HCV genotype 1a (n = 8), 1b (n = 2), 4 (n = 2)). Furthermore, 2 HCV/HIV-coinfected patients were denoted having received DAA therapy after liver transplantation (characteristics: HCV genotype 1a (n = 1), 4 (n = 1)).
Results: Applied DAA regimens were SOF/DAC (n = 7), SOF/LDV/RBV (n = 3), SOF/RBV (n = 3), PTV/r/OBV/DSV (n = 1), or PTV/r/OBV/DSV/RBV (n = 1), respectively. All patients achieved SVR 12, in the end. In one patient, HCV relapse occurred after 24 weeks of SOF/DAC therapy; subsequent treatment with 12 weeks PTV/r/OBV/DSV achieved SVR 12. One patient underwent liver transplantation while on DAA treatment. Analysis of liver function revealed either stable parameters or even significant improvement during DAA therapy and in follow-up. MELD scores were found to improve in 9/13 therapies in patients on the waiting list for liver transplantation; in only 2 patients a moderate increase of MELD scores persisted at the end of follow-up.
Conclusion: DAA treatment was safe and highly effective in this nation-wide cohort of patients with HCV/HIV-coinfection awaiting liver transplantation or being transplanted.